Substance / Medication

Dorzolamide hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata.
Wirtitsch Matthias G, Findl Oliver, Heinzl Harald et al. · Arch Ophthalmol · 2007
PMID: 17923541RCT
Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery.
Ammar H O, Salama H A, Ghorab M et al. · Drug Dev Ind Pharm · 2010
PMID: 20545523Observational
Additive effect of dorzolamide hydrochloride to patients taking travoprost: a retrospective study.
Boyer Stephen, Gay Dax · Optometry · 2008
PMID: 18722961Observational
Advances in dorzolamide hydrochloride delivery: harnessing nanotechnology for enhanced ocular drug delivery in glaucoma management.
Pardeshi Sagar R, Gholap Amol D, Hatvate Navnath T et al. · Discov Nano · 2024
PMID: 39656411ReviewFull text (PMC)
Statistically optimized liposomal formulation of dorzolamide hydrochloride for sustained ocular delivery:and allergic evaluation in rabbit.
Paul Susanta, Bose Anannya, Ray Kunal et al. · Drug Dev Ind Pharm · 2026
PMID: 41548087Other
Quality by design steered approach for co-encapsulation of timolol maleate and dorzolamide hydrochloride in injectable liposomes.
Verma Piyush, Rajpurohit Rahul, Yadav Khushwant S · Int J Pharm · 2024
PMID: 39154918Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dorzolamide hydrochloride (substance)
SNOMED CT
126154004
UMLS CUI
C0771293

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.